selected scholarly activity
-
chapters
- Infective Endocarditis. 63-70. 2018
-
conferences
- The Utility of Echocardiogram in the Workup of Ischemic Stroke Patients. Canadian Journal of Neurological Sciences. 73-77. 2024
- NAVIGATE ESUS TRIAL: BACKGROUND AND RECRUITMENT CHALLENGES. International Journal of Stroke. 231-232. 2016
- A New Model for Stroke Prevention Clinics: Improving Access by Removing Triage. International Journal of Stroke. 54-54. 2016
- NAVIGATE ESUS Trial: Background and Recruitment Challenges in Canada. International Journal of Stroke. 87-87. 2016
- Neurovascular manifestations of polycystic kidney disease. International Journal of Stroke. 52-52. 2016
- Frequency of Intracranial Arterial Imaging and its Yield in Consecutive Patients with Non-lacunar Cryptogenic Ischemic Stroke: ESUS Global Registry. Stroke. 2016
- Improving access to the stroke prevention clinic by removing triage. International Journal of Stroke. 2-2. 2015
- Prevalence of potential minor risk sources of embolism in patients with embolic stroke of undetermined source (ESUS) - A global survey. International Journal of Stroke. 12-12. 2015
- Global survey of the frequency of AF-associated stroke and its detection. International Journal of Stroke. 267-267. 2015
- Frequency and Features of Patients with Embolic Stroke of Undetermined Source(ESUS). Stroke. E267-E268. 2014
-
journal articles
- Thrombectomy in young adults with embolic stroke of undetermined source: Analysis of the Young ESUS study. Journal of Stroke and Cerebrovascular Diseases. 33:107811-107811. 2024
- Canadian Stroke Best Practice Recommendations, 7th Edition: Cerebral Venous Thrombosis, 2024. Canadian Journal of Neurological Sciences. 1-57. 2024
- Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry. International Journal of Stroke. 19:470-477. 2024
- Transcranial Doppler ultrasound to evaluate the risk of hyperperfusion after endovascular stroke thrombectomy. Journal of Neuroimaging. 34:50-54. 2024
- Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis. Stroke. 54:2724-2736. 2023
- Current and future advances in practice: a practical approach to the diagnosis and management of primary central nervous system vasculitis. Rheumatology Advances in Practice. 7:rkad080. 2023
- Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials. Canadian Journal of Cardiology. 39:187-197. 2023
- Management of a Thrombus in a Dolichoectatic Basilar Artery Secondary to Fabry Disease. Canadian Journal of Neurological Sciences. 50:149-151. 2023
- Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy. International Journal of Stroke. 17:799-805. 2022
- Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis. European Stroke Journal. 7:92-98. 2022
- Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source. JAMA Neurology. 79:450-450. 2022
- Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial. Stroke. 53:45-52. 2022
- Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices. Thromb Update. 5:100086-100086. 2021
- Histopathologic analysis of retrieved cerebral thrombi in acute ischemic stroke patients with proximal anterior circulation occlusions amenable to endovascular thrombectomy. Journal of the Neurological Sciences. 429:117617-117617. 2021
- Novel Vascular Anastomoses and Moyamoya Disease in a Woman with Down Syndrome. Canadian Journal of Neurological Sciences. 48:417-418. 2021
- Intracranial Atherosclerotic Plaque and Embolic Stroke of Undetermined Source. Journal of the American College of Cardiology. 77:692-694. 2021
- In-Hospital Delays for Acute Stroke Treatment Delivery During the COVID-19 Pandemic. Canadian Journal of Neurological Sciences. 48:59-65. 2021
- Statin treatment and cerebral microbleeds: A systematic review and meta-analysis. Journal of the Neurological Sciences. 420:117224-117224. 2021
- Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source. JAMA Neurology. 77:1233-1233. 2020
- Oral factor Xa inhibitors and risk of subdural hematoma. Neurology. 95:e480-e487. 2020
- Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy. Journal of Stroke and Cerebrovascular Diseases. 29:104936-104936. 2020
- Herpes Simplex Virus Type 2 Encephalitis Presenting as Multifocal Hemorrhagic Stroke. Canadian Journal of Neurological Sciences. 47:563-565. 2020
- Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta‐analysis of randomized trials. European Journal of Neurology. 27:1023-1027. 2020
- Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial. European Journal of Neurology. 27:841-848. 2020
- Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source. Stroke. 51:938-943. 2020
- Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes. JAMA Neurology. 77:43-43. 2020
- Central Nervous System Involvement with Chronic Lymphocytic Leukemia. Canadian Journal of Neurological Sciences. 46:640-641. 2019
- Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation. JAMA Neurology. 76:764-764. 2019
- Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurology. 17:1053-1060. 2018
- Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT). American Heart Journal. 201:160-163. 2018
- Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]). American Journal of Cardiology. 121:584-589. 2018
- Embolic Stroke of Undetermined Source. Stroke. 48:867-872. 2017
- Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke. Stroke. 47:2197-2202. 2016
- Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry. International Journal of Stroke. 11:526-533. 2016
- Age disparity in diagnostic evaluation of stroke patients: Embolic Stroke of Undetermined Source Global Registry Project. European Stroke Journal. 1:130-138. 2016
- What's New in Stroke? Phase III Randomized Clinical Trials of 2012–2014. International Journal of Stroke. 10:790-795. 2015
- In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age. ACP journal club. 160:JC7-JC7. 2014